MCRB Financials
Seres Therapeutics Inc - Financial statements & key metrics
Stock Price
$5.34
Market Cap
$109.77M
P/E Ratio
18.0
EPS
$0.88
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$136,000
EPS (Diluted)
$0.00
Balance Sheet Highlights
Total Assets
$139.81M
Total Liabilities
$126.03M
Shareholders Equity
-
Cash & Equivalents
$30.79M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-148.61M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-6403.7%
Net Margin
1536.8%
ROE
16.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MCRB revenue?
View MCRB's income statement for detailed revenue data.
Is MCRB profitable?
MCRB reported a profit of $136,000 in the most recent quarter. The net profit margin is 1536.8%.
What is MCRB market cap?
MCRB has a market capitalization of $109.77M, making it a small-cap stock.
Does MCRB have debt?
View MCRB's balance sheet for debt information.
What is MCRB cash flow?
Cash flow data is available in the full financial statements.